Antisialagogues are medications often used to manage and treat patients with noisy breathing near the end of life. These medications are members of the antimuscarinic class. This educational activity reviews the indications, actions, and contraindications for antisialagogues as agents in the management of noisy breathing near the end of life; use in other applicable disorders will also be discussed. This activity highlights the mechanism of action, adverse event profile, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions pertinent for interprofessional team members in the management of patients with noisy breathing near the end of life and related conditions.

**Objectives:**
- Review the monitoring requirements for patients receiving antisialagogues.
- Describe the pathophysiology of antisialagogue toxicity.
- Identify the indications for administration of antisialagogues in the management of noisy breathing near the end of life.
- Explain the importance of collaboration and communication among the interprofessional team to enhance care coordination for patients affected by noisy breathing near the end of life receiving antisialagogues.